Literature DB >> 28647740

Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Makito Miyake1, Yosuke Morizawa, Shunta Hori, Nagaaki Marugami, Kota Iida, Kenta Ohnishi, Daisuke Gotoh, Yoshihiro Tatsumi, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka, Keiji Shimada, Noboru Konishi, Kiyohide Fujimoto.   

Abstract

OBJECTIVE: The present study evaluated the clinical relevance of an integrative preoperative assessment of inflammation-, nutrition-, and muscle-based markers for patients with muscle-invasive bladder cancer (MIBC) undergoing curative radical cystectomy (RC).
METHODS: The analysis enrolled 117 patients and the variables included age, body mass index (BMI), neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, modified Glasgow Prognostic Score (mGPS), prognostic nutritional index (PNI), Controlling Nutritional Status score, psoas muscle index (PMI), and peak expiratory flow (PEF). The correlations among the variables were evaluated and their prognostic values after RC were tested.
RESULTS: Three inflammation markers (ratios of blood cell counts) were positively correlated (p < 0.0001). The PNI and the BMI were positively correlated (p = 0.04), although they were inversely correlated with the three inflammation markers (p < 0.0001). Age was not significantly correlated with the inflammation markers and PMI, although older age was associated with lower PNI and lower PEF. The disease-specific survival was independently predicted by T4 tumor, positive N status, and decreased PNI. Overall survival was independently predicted by T4 tumor, mGPS, and pretreatment sarcopenia status.
CONCLUSIONS: The inflammation-, nutrition-, and muscle-based markers would be useful risk assessment tools for MIBC.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Bladder cancer; Inflammation; Nutrition; Prognostic factor; Radical cystectomy; Sarcopenia; Skeletal muscle; Surgery

Mesh:

Substances:

Year:  2017        PMID: 28647740     DOI: 10.1159/000477405

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  24 in total

1.  Predicting Overall Survival Using Preoperative Nutritional and Inflammation Status for Colorectal Cancer.

Authors:  Tamuro Hayama; Tsuyoshi Ozawa; Mitsuo Tsukamoto; Yoshihisa Fukushima; Ryu Shimada; Keijiro Nozawa; Keiji Matsuda; Shoichi Fujii; Takeo Fukagawa; Yojiro Hashiguchi
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy.

Authors:  Shinya Abe; Hiroaki Nozawa; Kazushige Kawai; Kazuhito Sasaki; Koji Murono; Shigenobu Emoto; Junko Kishikawa; Tsuyoshi Ozawa; Yuichiro Yokoyama; Yuzo Nagai; Hiroyuki Anzai; Hirofumi Sonoda; Soichiro Ishihara
Journal:  Int J Colorectal Dis       Date:  2021-10-11       Impact factor: 2.571

3.  Impact of Colon Cancer Location on the Prognostic Significance of Nutritional Indexes and Inflammatory Markers.

Authors:  Tamuro Hayama; Tsuyoshi Ozawa; Kentaro Asako; Rie Kondo; Kohei Ono; Yuka Okada; Mitsuo Tsukamoto; Yoshihisa Fukushima; Ryu Shimada; Keijiro Nozawa; Keiji Matsuda; Shoichi Fujii; Takeo Fukagawa; Yojiro Hashiguchi
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

4.  The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy.

Authors:  Yuki Nemoto; Tsunenori Kondo; Hiroki Ishihara; Toshio Takagi; Hironori Fukuda; Kazuhiko Yoshida; Junpei Iizuka; Hideki Ishida; Kazunari Tanabe
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature.

Authors:  Paola Irene Ornaghi; Luca Afferi; Alessandro Antonelli; Maria Angela Cerruto; Katia Odorizzi; Alessandra Gozzo; Livio Mordasini; Agostino Mattei; Philipp Baumeister; Julian Cornelius; Alessandro Tafuri; Marco Moschini
Journal:  World J Urol       Date:  2020-06-09       Impact factor: 4.226

6.  Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.

Authors:  Makito Miyake; Takuya Owari; Takashi Iwamoto; Yosuke Morizawa; Shunta Hori; Nagaaki Marugami; Keiji Shimada; Kota Iida; Kenta Ohnishi; Daisuke Gotoh; Yoshihiro Tatsumi; Yasushi Nakai; Takeshi Inoue; Satoshi Anai; Kazumasa Torimoto; Katsuya Aoki; Tatsuo Yoneda; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Support Care Cancer       Date:  2017-10-11       Impact factor: 3.603

7.  Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.

Authors:  Feng Qi; Yunqiu Xu; Yuxiao Zheng; Xiao Li; Yang Gao
Journal:  Ann Transl Med       Date:  2019-10

8.  Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.

Authors:  Ryutaro Shimizu; Masashi Honda; Shogo Teraoka; Tetsuya Yumioka; Noriya Yamaguchi; Bunya Kawamoto; Hideto Iwamoto; Shuichi Morizane; Katsuya Hikita; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2021-10-04       Impact factor: 3.402

Review 9.  Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.

Authors:  Andrea Mari; Riccardo Campi; Riccardo Tellini; Giorgio Gandaglia; Simone Albisinni; Mohammad Abufaraj; Georgios Hatzichristodoulou; Francesco Montorsi; Roland van Velthoven; Marco Carini; Andrea Minervini; Shahrokh F Shariat
Journal:  World J Urol       Date:  2017-11-16       Impact factor: 4.226

10.  Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab.

Authors:  Takuto Shimizu; Makito Miyake; Shunta Hori; Kazuki Ichikawa; Chihiro Omori; Yusuke Iemura; Takuya Owari; Yoshitaka Itami; Yasushi Nakai; Satoshi Anai; Atsushi Tomioka; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Diagnostics (Basel)       Date:  2020-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.